Atlas Trials

Fed Study of Anagrelide Hydrochloride Capsules 1 mg to Agrylin® Capsules 1 mg

Clinical trial NCT00648765 · COMPLETED

Trial details

NCT number
NCT00648765
Sponsor
Mylan Pharmaceuticals Inc
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2003-01-01
Primary completion
2003-01-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.